Steven Cohen Prometheus Biosciences Inc

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$40.6

Avg closing price
Price range
Steven Cohen Portfolio Stock Details (RXDX)

10 Steven Cohen Prometheus Biosciences Trades

The first Prometheus Biosciences trade was made in Q1 2021. Since then Steven Cohen bought shares three more times and sold shares on six occasions. The investor sold all their shares in Q2 2023 and doesn't own any shares in Prometheus Biosciences anymore.

Avg closing price
Price range
Sold -1.47 Million shares Q2 2023
Avg closing price $181.30
Price range $108.58 - $199.92
Increased shares by 15.7% (+199 Thousand shares) Q1 2023
Avg closing price $115.10
Price range $103.46 - $126.29
Increased shares by 113.5% (+673 Thousand shares) Q4 2022
Avg closing price $64.85
Price range $36.06 - $117.21
Sold 56.6% shares (-774 Thousand shares) Q3 2022
Avg closing price $45.76
Price range $28.17 - $59.01
Increased shares by 2632.9% (+1.32 Million shares) Q2 2022
Avg closing price $28.98
Price range $22.39 - $38.94
Sold 62.8% shares (-84.5 Thousand shares) Q1 2022
Avg closing price $39.53
Price range $30.13 - $50.00
Sold 81.7% shares (-602 Thousand shares) Q4 2021
Avg closing price $31.30
Price range $22.28 - $39.54
Sold 3.6% shares (-27.7 Thousand shares) Q3 2021
Avg closing price $23.60
Price range $20.89 - $26.96
Sold 4.5% shares (-35.9 Thousand shares) Q2 2021
Avg closing price $22.31
Price range $16.80 - $29.65
New holding (+800 Thousand shares) Q1 2021
Avg closing price $20.65
Price range $16.51 - $25.29
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.